BackPear Therapeutics Overview

Pear Therapeutics Long Term Debt

Track Pear Therapeutics's long-term debt ($8.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$8.18M

Peer average

Loading

Pear Therapeutics Long Term Debt History

Loading

Pear Therapeutics vs. peers: Long Term Debt Comparison

Loading

Pear Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Pear Therapeutics (PEAR) FAQ

Pear Therapeutics (PEAR) currently reports a long-term debt of $8.2M as of December 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Pear Therapeutics's long-term debt history and peer comparisons.

Pear Therapeutics's long-term debt changed from $0 to $8.2M (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pear Therapeutics reported $8.2M in long-term debt as of December 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $8.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pear Therapeutics, and consider following PEAR for alerts when major investors trade the stock.